Formulation having improved absorbability of low-soluble and/or low-membrane-permeable drug
AssigneeMedrx Co., Ltd.
InventorsTakashi NAKAE, Yasushi MIWA, Hidetoshi HAMAMOTO, Noboru TATSUMI, Yutaka YAMAGATA
Life of this patent
Estimating the term…
Loading patent…
AssigneeMedrx Co., Ltd.
InventorsTakashi NAKAE, Yasushi MIWA, Hidetoshi HAMAMOTO, Noboru TATSUMI, Yutaka YAMAGATA
Estimating the term…
The present invention provides a pharmaceutical composition comprising a drug with low solubility and/or low permeability and an ionic liquid, wherein the ionic liquid is an anion ingredient and a cation ingredient, the anion ingredient is oleic acid or isostearic acid, and the cation ingredient is selected from a cationic lipid as well as a transmucosal absorption enhancer or a gastrointestinal absorption enhancer comprising an ionic liquid, wherein the ionic liquid is an anion ingredient and a cation ingredient, the anion ingredient is oleic acid or isostearic acid, and the cation ingredient is selected from a cationic lipid.
A pharmaceutical composition comprising a drug with low solubility and/or low permeability and an ionic liquid, wherein the ionic liquid comprises an anion ingredient and a cation ingredient, the anion ingredient is oleic acid or isostearic acid, and the cation ingredient is selected from a cationic lipid.
A transmucosal absorption enhancer comprising an ionic liquid, wherein the ionic liquid comprises an anion ingredient and a cation ingredient, the anion ingredient is oleic acid or isostearic acid, and the cation ingredient is selected from a cationic lipid, provided that a drug is not comprised.
A gastrointestinal absorption enhancer comprising an ionic liquid, wherein the ionic liquid comprises an anion ingredient and a cation ingredient, the anion ingredient is oleic acid or isostearic acid, and the cation ingredient is selected from a cationic lipid, provided that a drug is not comprised.
Dependencies are inferred from the claim text.